A
A. Wisanto
Researcher at VU University Amsterdam
Publications - 36
Citations - 1669
A. Wisanto is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: In vitro fertilisation & Embryo transfer. The author has an hindex of 21, co-authored 36 publications receiving 1655 citations.
Papers
More filters
Journal ArticleDOI
The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT
Johan Smitz,Paul Devroey,M. Camus,J. Deschacht,I. Khan,C. Staessen,L. Van Waesberghe,A. Wisanto,A.C. Van Steirteghem +8 more
TL;DR: Endometrial biopsies showing inadequate development were observed after ovarian stimulation with the GnRH agonist Buserelin and HMG for IVF or GIFT when luteal supplementation was omitted, and temporarily defective function of the corpus luteum was evidenced by measuring serum progesterone, 17 beta-oestradiol and 17-hydroxyprogesterone.
Journal ArticleDOI
Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.
Johan Smitz,Paul Devroey,P. Braeckmans,M. Camus,I. Khan,C. Staessen,L. Van Waesberghe,A. Wisanto,A.C. Van Steirteghem +8 more
TL;DR: The addition of the gonadotropin releasing hormone (GnRH) agonist Buserelin to human menopausal gonadotrophin/human chorionic gonadotropic hormone (HMG/HCG) during ovarian stimulation was evaluated in 23 cycles of 21 women who previously had unsuccessful IVF treatments when stimulated with clomiphene--HMG-HCG.
Journal ArticleDOI
Comparative follow-up study of 130 children born after intracytoplasmic sperm injection and 130 children born after in-vitro fertilization
Mary-Louise Bonduelle,J. Legein,M.-P. Derde,Ann Buysse,J. Schietecatte,A. Wisanto,Paul Devroey,A. Van Steirteghem,Ingeborg Liebaers +8 more
TL;DR: There was no difference in the paediatric follow-up of 130 children Born after ICSI and 130 children born after conventional IVF in age-matched control patients, and all karyotypes were normal except for one prenatally detected mosaicism.
Journal ArticleDOI
Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization
TL;DR: It is confirmed that the ovulatory HCG dose is the most important factor in inducing this severe complication and luteal supplementation with HCG and/or HCG production during implantation could exacerbate OHSS.
Journal ArticleDOI
Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol
Johan Smitz,Peter Erard,M. Camus,Paul Devroey,Herman Tournaye,A. Wisanto,A.C. Van Steirteghem +6 more
TL;DR: It is concluded that gonadotrophin function remained impaired until the end of the luteal phase after desensitization and flare-up GnRH-agonist and HMG stimulation protocols.